CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorJohns Hopkins University

About this trial

This study is a prospective two-arm, single blind randomized controlled trial design to compare the clinical effectiveness of telemedicine-delivered, 6-session, standardized cognitive behavioral therapy for insomnia (CBT-I) and mindfulness-based treatment for insomnia (MBTI) in treating insomnia symptoms and ameliorating depressive symptoms in persons with mild to moderate TBI and comorbid Post-Traumatic Stress Symptoms (PTSS) and insomnia symptoms in a 360 patients. Participants will undergo assessment (psychosocial questionnaires, neurocognitive testing, sleep monitoring) at baseline, at the end of treatment, and at 2-, 6- and 12-weeks post-treatment. The primary outcome is sleep as measured by the Insomnia Severity Index (ISI).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Current or former member of the uniform services

Meet the Veterans Affairs Medical Center (VAMC) Department of Defense (DoD) criteria for TBI;

Time duration since traumatic brain injury (TBI) injury >90 days

Insomnia symptom duration >90 days

Disqualifiers

History of neurological diseases other than TBI and not attributable to TBI

Sleep apnea [apnea hypopnea index (AHI) >15; individuals with mild apnea (AHI > 5 and <15) will be informed, but allowed to participate]. Participants who use a continuous positive airway pressure (CPAP) device for sleep apnea will be eligible for participation if they are below the apnea/hypopnea cutoff while using CPAP, are adherent to using the device (> 4 hours/night 21/30 consecutive days) and agree to continue using the device during study participation.

Lastly, people using psychotropic medications may be included if they are on a stable dosage for the last three weeks prior to the study.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Mindfulness-based treatment for insomnia (MBTI)

    Behavioral

    A 6-week intervention that uses the principles and practices of mindfulness meditation along with behavioral strategies (stimulus control, sleep restriction therapy) to reduce symptoms of insomnia

  • Cognitive behavioral therapy for insomnia (CBT-I)

    Behavioral

    Standard of care for adults with chronic insomnia. 6-week program that uses behavioral techniques to decrease psychophysiological arousal and increase sleep propensity to deepen and consolidate sleep.

Treatment groups

360 Participants
are divided into 2 treatment groups
Group A: Cognitive behavioral therapy for insomnia (CBT-I)Active comparator 1 intervention
Group B: Mindfulness-based treatment for insomnia (MBTI)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Insomnia severity as assessed by the insomnia severity index (ISI)

Insomnia symptoms and severity measured by insomnia severity index (ISI); score range: 0-28; Higher scores are associated with greater insomnia symptoms

Time frame
At the end of treatment, and 2-, 6- and 12-weeks post treatment

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Johns Hopkins University

Lead sponsor

Congressionally Directed Medical Research Programs

Collaborator